Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Br J Psychiatry ; 168(3): 324-9, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8833686

ABSTRACT

BACKGROUND: This study employed an alternative method for assessing serotonergic function to further evaluate our finding that cerebrospinal fluid (CSF) 5-hydroxyindole acetic acid (5-HIAA) in depressed suicide attempters with a lifetime history of higher lethality suicide attempts is significantly lower compared to depressed patients who have a history of low lethality suicide attempts. METHOD: We used dl-fenfluramine (60 mg) as a neuroendocrine probe to examine the serotonin system in 41 in-patients with a DSM-III-R major depressive episode, divided into two groups on the basis of a lifetime history of high or low lethality suicide attempts. Fenfluramine challenge test outcome was defined as the maximum prolactin response in the five hours following fenfluramine. RESULTS: Patients with a history of a higher lethality suicide attempt had a significantly lower prolactin response to fenfluramine, even when controlling for cortisol, age, sex, weight, comorbid cluster B personality disorder, pharmacokinetic and menstrual cycle effects. CONCLUSIONS: The data provide further support for the hypothesis that serotonin dysfunction is associated with more lethal suicide attempts, and suggests that higher lethality suicide attempters or failed suicides resemble completed suicides both behaviourally and biochemically.


Subject(s)
Depressive Disorder/drug therapy , Fenfluramine , Prolactin/metabolism , Suicide, Attempted/psychology , Adult , Body Weight , Depressive Disorder/complications , Depressive Disorder/psychology , Female , Fenfluramine/cerebrospinal fluid , Fenfluramine/pharmacology , Fenfluramine/therapeutic use , Humans , Hydrocortisone/metabolism , Longitudinal Studies , Male , Menstrual Cycle/drug effects , Personality Disorders/complications , Serotonin/cerebrospinal fluid , Sex Factors
2.
Rev Neurol (Paris) ; 139(10): 589-92, 1983.
Article in French | MEDLINE | ID: mdl-6196830

ABSTRACT

Serotoninergic function has been evaluated in 15 H.C. patients. Therapeutic results obtained with an inhibitor of 5 HT reuptake (Fenfluramine) were evaluated in comparison to the effects of L-5HTP, CSF-5HIAA measurements were performed is each case before and after treatment. The pathological role of 5HT impairment in H. C. can not be excluded by the behavioral effects and CSF-5HIAA modifications that were observed.


Subject(s)
5-Hydroxytryptophan/therapeutic use , Fenfluramine/therapeutic use , Huntington Disease/drug therapy , Adult , Female , Fenfluramine/cerebrospinal fluid , Homovanillic Acid/cerebrospinal fluid , Humans , Huntington Disease/cerebrospinal fluid , Hydroxyindoleacetic Acid/cerebrospinal fluid , Male , Methoxyhydroxyphenylglycol/cerebrospinal fluid , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...